In vitro manogepix susceptibility testing of South African Emergomyces africanus, Emergomyces pasteurianus , and Blastomyces emzantsi clinical isolates
Mutations in transcription factors that confer fluconazole resistance also confer reduced susceptibility to manogepix in Candida auris ( Candidozyma auris ), Candida albicans , Candida parapsilosis , and Candida glabrata ( Nakaseomyces glabratus )
The activity of new drug manogepix against clinical isolates of Candida spp. resistant to at least one classical antifungal drug
